Christopher David Ozeroff Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher David Ozeroff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher David Ozeroff. Christopher David Ozeroff is S.V.P., General Counsel in ARCA biopharma, Inc. ($ABIO) and SVP & GENERAL COUNSEL in ARCA biopharma, Inc. ($ABIO).
Latest Insider Trading Transactions of Christopher David Ozeroff
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2017 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Sell | S | 2.41 | 418 | 1,007 | 17,517 | 17.9 K to 17.5 K (-2.33 %) |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Option Exercise | A | 2.50 | 24,000 | 60,000 | 24,000 | |
| Sep 21 2016 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Sell | S | 2.89 | 1,185 | 3,425 | 18,400 | 19.6 K to 18.4 K (-6.05 %) |
| Jun 13 2016 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Option Exercise | A | 3.30 | 30,200 | 99,660 | 30,200 | |
| Jun 13 2016 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Option Exercise | A | 3.30 | 14,800 | 48,840 | 14,800 | |
| Apr 06 2016 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Sell | S | 3.52 | 366 | 1,288 | 19,585 | 20 K to 19.6 K (-1.83 %) |
| Mar 02 2016 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Sell | S | 3.51 | 458 | 1,608 | 19,951 | 20.4 K to 20 K (-2.24 %) |
| Sep 21 2015 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | S.V.P., General Cou ... | Sell | S | 6.32 | 1,129 | 7,135 | 20,409 | 21.5 K to 20.4 K (-5.24 %) |
| Jul 07 2010 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | SVP & GENERAL COUNS ... | Option Exercise | M | 0.06 | 4,101 | 246 | 0 | |
| Jul 07 2010 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | SVP & GENERAL COUNS ... | Sell | J | 0.00 | 2,051 | 0 | 41,758 | 43.8 K to 41.8 K (-4.68 %) |
| Jul 07 2010 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | SVP & GENERAL COUNS ... | Buy | M | 0.06 | 4,101 | 246 | 43,809 | 39.7 K to 43.8 K (+10.33 %) |
| May 28 2010 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | SVP & GENERAL COUNS ... | Sell | J | 0.00 | 39,709 | 0 | 39,708 | 79.4 K to 39.7 K (-50.00 %) |
| Feb 22 2010 | ABIO | ARCA biopharma, In ... | Ozeroff Christopher David | SVP & GENERAL COUNS ... | Option Exercise | A | 2.97 | 6,400 | 19,008 | 6,400 |
Page: 1